New 'Artificial Pancreas' system aims for better blood sugar control
NCT ID NCT07401901
Summary
This study is testing a new automated insulin delivery system called the NMX8. It aims to see if this new system is as safe and effective as other commercially available systems at helping adults with type 1 diabetes keep their blood sugar in a healthy range. About 230 participants will use either the new NMX8 system or continue with their current therapy for six months to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliera Ospedale Niguarda Cà Granda
Milan, Italy
-
Azienda Ospedaliera Universitaria Federico II
Naples, Italy
-
CHU de Nîmes - Hôpital Universitaire Caremeau
Nîmes, France
-
Centre Hospitalier Universitaire de Caen
Caen, France
-
Diabates Center Amsterdam
Amsterdam, Netherlands
-
Die Praxisgemeinschaft für Endokrinologie und Diabetes
Rostock, Germany
-
Fondazione Policlinico Universitario Agostino Gemelli - Università Cattolica del Sacro Cuore
Roma, Italy
-
Herz- und Diabeteszentrum NRW - Ruhr-Universität Bochum
Bad Oeynhausen, Germany
-
Hopital Lariboisiere & Fernand-Widal
Paris, France
-
Hospices Civils de Lyon (DIAB-e CARE)
Lyon, France
-
Hospital Clínico San Carlos
Madrid, Spain
-
Hospital Universitari Clínic de Barcelona
Barcelona, Spain
-
Hôpital Michallon - CHU Grenoble
Grenoble, France
-
Leicester General Hospital
Leicester, United Kingdom
-
Maastricht University Medical Center (UMC)
Maastricht, Netherlands
-
Manchester University NHS Foundation Trust - Manchester Royal Infirmary
Manchester, United Kingdom
-
Policlinico Sant' Orsola - Malpighi
Bologna, Italy
-
University Hospitals of Derby and Burton NHS Foundation Trust - Florence Nightingale Community Hospital
Derby, United Kingdom
-
ZGT Almelo
Almelo, Netherlands
-
Zentrum für digitale Diabetologie Hamburg
Hamburg, Germany
Conditions
Explore the condition pages connected to this study.